- Home
- MBC vs AMPH Comparison
MBC vs AMPH Comparison
Compare MBC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- AMPH
- Stock Information
- Founded
- MBC 1954
- AMPH 1996
- Country
- MBC United States
- AMPH United States
- Employees
- MBC N/A
- AMPH N/A
- Industry
- MBC Agricultural Chemicals
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- AMPH Health Care
- Exchange
- MBC Nasdaq
- AMPH Nasdaq
- Market Cap
- MBC 2.3B
- AMPH 2.5B
- IPO Year
- MBC N/A
- AMPH 2014
- Fundamental
- Price
- MBC $16.05
- AMPH $39.97
- Analyst Decision
- MBC Strong Buy
- AMPH Buy
- Analyst Count
- MBC 1
- AMPH 4
- Target Price
- MBC $23.00
- AMPH $60.33
- AVG Volume (30 Days)
- MBC 675.4K
- AMPH 458.4K
- Earning Date
- MBC 11-05-2024
- AMPH 11-06-2024
- Dividend Yield
- MBC N/A
- AMPH N/A
- EPS Growth
- MBC N/A
- AMPH 17.38
- EPS
- MBC 1.14
- AMPH 3.01
- Revenue
- MBC $2,709,800,000.00
- AMPH $723,549,000.00
- Revenue This Year
- MBC $2.41
- AMPH $16.86
- Revenue Next Year
- MBC $7.56
- AMPH $10.07
- P/E Ratio
- MBC $14.25
- AMPH $13.58
- Revenue Growth
- MBC N/A
- AMPH 20.33
- 52 Week Low
- MBC $13.37
- AMPH $36.56
- 52 Week High
- MBC $20.67
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- MBC 35.67
- AMPH 30.85
- Support Level
- MBC $15.63
- AMPH $40.37
- Resistance Level
- MBC $17.02
- AMPH $45.39
- Average True Range (ATR)
- MBC 0.40
- AMPH 1.24
- MACD
- MBC -0.06
- AMPH -0.25
- Stochastic Oscillator
- MBC 19.23
- AMPH 7.06
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers, and builders.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.